2Maddrey WC. Hepatitis B: An important public health issue. J Med Virol, 2000 Jul, 61 (3): 362
3汪俊韬主编.病毒性肝炎治疗学.天津:科学技术出版社,1996.749
4Schiff Eugene R. Lamivudine for Hepatitis B in Clinical Practice. Journal of Medical. Vicology, 2000, 61:386
5Schalm SW, Heathcote J, Cianciara J, et al. Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: A randomised trial. Gut, 2000 Apr, 64 (4): 450
6Chang TT, LaiCL, Leung NWY, etal. IncreasesinHBeAgseroconversion and continued ALT normalisation in Asian chronic HBV(CHB) patients treated with lamivudine for four yearw. Antiviral Ther, 2000, 5 (suppl 1): 44
7Lai CL, Chien RN, Leung NW, et al. A one- year trial of lamivudine for chronic hepatitisB. NEngJ Med, 1998, 339:61
8Dienstag J, schiffE, Wright T, etal. Lamivudinetreatment forone year in previously untreated US hepatitis B: histologic improvement and hepatits B e-antigen (HBeAg) seroconversion. Gastroenterology,1998, 29:889
9Schief E, Karayalcin S, Grimm I, et al. A placebo controlled study of lamivudine and interferon a- 2b in patients with chronic hepatitis B who previously failed interferon therapy. Hepatology, 1998, 28:388A (Abstract 901)
10WongDK, CheungAM, O'RurkeK, etal. Effect of alpha- interferon treatment in patients with hepatitis B e antigen- positive chronic hepatitis B. A meta- analysis. Ann Inter Med, 1993, 199:312
